Researchers at UCLA have developed a new method to bioprint miniature tumor organoids that can mimic the function and architecture of real tumors. This allows for the accurate measurement of individual organoids, enabling the identification of personalized treatments for people with rare or hard-to-treat cancers.
A new targeted therapy drug vorasidenib has been shown to extend treatment time without worsening glioma in people with IDH1 and IDH2 mutations. The study suggests a possible new treatment option for slow-growing but deadly brain tumors, delaying chemotherapy and radiation.
A study found that adding ribociclib to hormone therapy significantly improves invasive disease-free survival rates in patients with stage 2 or 3 HR positive/HER2 negative breast cancer. The combination therapy reduced the risk of cancer recurrence by 25%, with a three-year invasive disease-free survival rate of 90.4%.
Researchers at UCLA Health highlight the impact of test results on lung cancer screening adherence and the potential unnecessary use of axillary ultrasound in breast cancer diagnostics. Meanwhile, a new AI system helps check endotracheal tube placement with high accuracy and user satisfaction.
Researchers found that targeted deep-brain stimulation during a critical sleep cycle improved memory consolidation in patients with epilepsy. The study provided physiological evidence from inside the human brain supporting the main theory for how memory is consolidated during sleep.
A recent study published in Annals of Internal Medicine found that elderly hospitalized patients treated by physicians with MD or DO degrees had virtually identical mortality rates, readmissions, length of stay, and healthcare spending. The results suggest high-quality care regardless of the physician's educational background.
A recent study led by UCLA researchers has identified a potential new strategy for treating glioblastoma by targeting a specific metabolic process in cancer cells. The study found that disrupting this process could make glioblastoma cells more vulnerable to cell death, offering hope for new treatment options.
A study of nearly 67,200 postmenopausal women found that the Fracture Risk Assessment Tool (FRAX) was inadequate for identifying osteoporotic fracture risk across racial/ethnic categories. However, the Osteoporosis Self-Assessment Tool (OST) was excellent for detecting osteoporosis within each category.
Researchers from the UCLA Jonsson Comprehensive Cancer Center are presenting findings on combination therapies for breast cancer and a potential new treatment for patients with recurrent glioma. A phase 3 study evaluating vorasidenib versus placebo in patients with residual or recurrent grade 2 glioma with an IDH1/2 mutation is also be...
A new UCLA study found that the accuracy of genetically-based disease predictions using polygenic scores (PGSs) varies significantly between individuals, even within traditionally considered homogeneous populations. PGS performance declines as genetic distance increases, and individual ancestry plays a crucial role in determining accur...
Researchers at UCLA Jonsson Comprehensive Cancer Center have found a potential therapeutic target, IL-21, to reduce endocrine autoimmune side effects from checkpoint immunotherapy. A specific group of immune cells play a central role in this autoimmune attack and blocking IL-21 prevents thyroid autoimmunity.
Researchers at UCLA and Harvard have identified 10 pesticides toxic to dopaminergic neurons, which play a key role in voluntary movement. The study used California's pesticide use database and found that co-exposure of certain pesticides increased toxicity, with combinations involving herbicides like trifluralin producing the most harm.
A new computer-modeling system, scDesign3, has been developed to generate realistic synthetic data for analyzing genetic makeup of cells. The system can help researchers evaluate and validate computational methods for tasks such as gene expression analysis and cell trajectory modeling.
Researchers have developed a zebrafish model to understand lipid transport across the blood-brain barrier, crucial for healthy nervous system development. The study provides key insights into how omega-3 fatty acids, particularly DHA, are transported into the brain and may enable targeted drug delivery.
A sharp increase in colchicine's price led to a 17% drop in its use and worsened disease control in gout patients. Patients turned to alternative medications with potentially different side effects, resulting in increased emergency department visits and specialist consultations.
Researchers found that people who perceived cognitive difficulties during COVID were more likely to experience physical symptoms of long COVID. The study suggests a psychological component for lingering SARS-CoV-2 symptoms in some patients.
Scientists have discovered potential broad-spectrum antivirals that target multiple families of RNA viruses, which pose a significant threat to future pandemics. The new agents showed promise in preventing and mitigating viral arthritis caused by Chikungunya virus and rescuing cells from harmful effects of other viruses.
Researchers analyzed genetic changes in organs of recently deceased patients with metastatic cutaneous melanoma to understand how the disease spreads and evolves. They found that cancer cells take advantage of specific organ environments, pointing to the need for distinct treatment approaches.
Researchers from UCLA will deliver presentations on innovative approaches to pediatric care, including a trauma-informed care assessment tool and a weight bias curriculum. A mobile phone pilot intervention is also being explored as a potential solution for preventing obesity in Latino preschool children.
Researchers from UCLA's Jonsson Comprehensive Cancer Center and Department of Urology will showcase significant advances in urologic oncology, female pelvic reconstruction, and more. The presentations highlight innovative treatments for kidney cancer, prostate cancer, and other conditions.
Researchers used a novel machine-learning technique called causal forest, which found that treating individuals with high estimated benefits provided better population health outcomes than the traditional high-risk approach. This approach targets those with high blood pressure and could lead to more effective treatment strategies.
Researchers at UCLA Health discovered that astrocytes, traditionally considered the brain's support system, are involved in obsessive-compulsive disorder-related behaviors. The study suggests that targeting both neurons and astrocytes may be effective for OCD treatment.
A study published in Cancer Cell found that prior treatments, such as CTLA-4 blockade, modify the response to anti-PD-1 checkpoint blockade therapy. The research analyzed data from over 500 patients and identified key factors associated with treatment response. This finding may help scientists create more precise future treatments.
A new UCLA study identifies sex-specific brain signatures associated with obesity in men and women, revealing differences in brain networks related to early life adversity, mental health, and sensory stimulation. The findings suggest the need for tailored interventions based on an individual's sex.
Researchers have linked higher lithium levels in drinking water to a moderately higher risk of autism spectrum disorder in offspring. The study found that mothers living in urban areas had a slightly stronger association between lithium exposure and autism risk.
Overdose mortality among people aged 65 and older has quadrupled, driven by illicit drugs like fentanyl, heroin, and synthetic opioids. Researchers call for updated Medicare coverage and harm reduction supplies to curb the trend.
Researchers discovered that 'dormant' cone photoreceptors in retinal degeneration continue to produce responses to light and drive retinal activity for vision. The study found that while cones have reduced sensitivity, ganglion cells retain their ability to respond to visual stimuli with similar spatial and temporal sensitivity.
A recent study found that the mitochondrial antioxidant MitoQ can reverse the detrimental effects of HIV and antiretroviral therapy on organs such as the brain, heart, and liver. The researchers used humanized mice infected with HIV and treated them with MitoQ for three months.
Researchers at UCLA successfully used base editing to correct a mutation causing rare immune deficiency CD3 delta SCID. The treatment corrected an average of 71% of patient stem cells and allowed them to produce fully functional T cells, suggesting long-term persistence of corrected blood stem cells.
A study published in Nature Immunology found that female mouse and human NK cells have more of a specific epigenetic regulator called UTX, which boosts anti-viral function while repressing NK cell numbers. This suggests that therapies need to be tailored to individual differences, including sex.
Researchers used PET and electron microscopy to create detailed maps of mitochondrial networks in lung tumors. They found distinct subpopulations of mitochondria organizing with organelles to support tumor cell metabolism.
A new meta-analysis found that sleeping fewer than six hours per night after COVID-19 vaccination was associated with a weakened antibody response. The study highlights the need for simple behavioral interventions like sufficient sleep to improve vaccine efficacy during the pandemic.
A new study has identified the steps by which immune cells recognize and respond to cancer cell mutations, providing insights into why some treatments work for certain patients but not others. Researchers believe their findings will lead to better, more personalized immunotherapies for patients whose immune systems currently do not app...
Researchers found that Black men have a higher mortality rate after surgery compared to other groups, with a 50% higher risk of death after elective procedures. The study suggests that structural racism, poor pre-operative care, and exposure to toxins may contribute to these disparities.
Researchers found that adding immunotherapy before surgical removal of stage III-IV melanoma significantly improved event-free survival compared to standard-of-care treatment. The study showed that neoadjuvant therapy is superior to the same therapy given in the adjuvant setting.
A new study has identified a biomarker, placental growth factor (PlGF), which is associated with cognitive impairment and dementia due to vascular brain injury. Higher levels of PlGF in the bloodstream are linked to increased risk of cognitive decline and cerebral small vessel disease.
Researchers use movie clips to study mouse brain activity, revealing novel ways to diagnose learning and memory disorders. The discovery points to new ways to tackle Alzheimer's and improve artificial intelligence.
A recent study found that breast cancer risk models can lead to vastly different recommendations for individual women, depending on the model used and threshold applied. The study highlighted the importance of considering both sensitivity and inaccurate classification when using these models.
New UCLA research finds that tobacco smoking and vaping can predispose healthy young people to increased inflammation and severe COVID-19. The study, published in Journal of Molecular Medicine, found higher levels of key proteins in plasma from smokers and vapers compared to non-smokers.
A new UCLA-led study found that many patients do not receive sufficient rehabilitation therapy after a stroke, which can lead to long-term disability. Hispanic patients were particularly affected, receiving lower amounts of physical and occupational therapy.
A new study found that financial coaching for parents of infants in a pediatric primary care setting reduced missed well-child care visit rates by half and improved vaccination receipt. The intervention, which connected parents to public benefits and cost-saving services, also increased monthly household income.
A recent study reveals that Native Americans have the highest rates of mortality from deaths of despair, including suicide, drug overdoses, and alcoholic liver disease. In contrast, white communities are often portrayed as being disproportionately affected by this phenomenon.
A new study by UCLA Jonsson Comprehensive Cancer Center identifies the DNA roots of resistance to targeted cancer therapy. The researchers found that a protein called DNA-PK plays a crucial role in the process of chromothripsis, which can lead to gene amplification and therapy resistance.
A Phase 3 clinical trial has shown that a four-drug chemotherapy regimen significantly increases overall survival and progression-free survival in patients with stage 4 pancreatic ductal adenocarcinoma. The study's results suggest that this more aggressive treatment approach may be considered for eligible patients.
Research reveals that commonly used antiretroviral drugs TAF and TDF directly impact mitochondria's energy production in immune cells. The study suggests a larger energy reduction when combined with other antiretrovirals, sparking concerns about potential long-term effects on human cells.
A new study found that MRI-guided radiotherapy is more effective than CT-guided therapy in reducing side effects and improving quality of life for patients with localized prostate cancer. The trial involved 154 patients, who experienced fewer toxicities and better outcomes when treated with MRI guidance.
A new classification system, MPATH-Dx Version 2.0, has been developed to simplify diagnoses of melanocytic skin lesions. The system categorizes lesions into four classes, providing guidance on treatment and surveillance for patients.
Researchers at UCLA Health have found that masks can prevent not only COVID-19 but also whooping cough, while obesity is linked to an increased risk of stroke and cognitive impairment. The institute has also designed a clinical trial to reduce the use of low-value treatments for Alzheimer's disease.
The AVID college preparatory program has been shown to have a positive effect on students' social networks, psycho-social outcomes, and health behaviors. Students who participated in the program had lower odds of using substances and associating with substance-using peers compared to those in usual school programs.
The phase 1 and phase 2 studies showed that ARV-471 was well-tolerated and could promote substantial estrogen receptor degradation in patients with advanced disease. The study has led to a randomized phase 3 trial comparing ARV-471 with a SERD in patients with ER-positive/HER2-negative advanced breast cancer.